Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| smooth muscle cell | 28 studies | 46% ± 19% | |
| fibroblast | 25 studies | 29% ± 11% | |
| pericyte | 22 studies | 32% ± 15% | |
| myofibroblast cell | 11 studies | 42% ± 19% | |
| platelet | 9 studies | 32% ± 11% | |
| cardiac muscle cell | 7 studies | 81% ± 24% | |
| adipocyte | 7 studies | 26% ± 9% | |
| type I pneumocyte | 7 studies | 24% ± 4% | |
| connective tissue cell | 6 studies | 26% ± 8% | |
| muscle cell | 4 studies | 60% ± 23% | |
| mesothelial cell | 3 studies | 20% ± 4% | |
| GABAergic neuron | 3 studies | 33% ± 13% | |
| glutamatergic neuron | 3 studies | 38% ± 17% | |
| megakaryocyte | 3 studies | 44% ± 15% | |
| adventitial cell | 3 studies | 19% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 65% | 4880.35 | 160 / 245 | 98% | 26.77 | 494 / 502 |
| esophagus | 70% | 11208.09 | 1008 / 1445 | 93% | 13.06 | 170 / 183 |
| uterus | 85% | 7851.28 | 145 / 170 | 75% | 12.03 | 346 / 459 |
| lung | 69% | 3268.13 | 400 / 578 | 90% | 11.70 | 1044 / 1155 |
| bladder | 81% | 6844.10 | 17 / 21 | 75% | 8.04 | 380 / 504 |
| intestine | 76% | 8065.87 | 730 / 966 | 75% | 8.70 | 396 / 527 |
| breast | 44% | 1566.18 | 202 / 459 | 94% | 9.64 | 1048 / 1118 |
| stomach | 50% | 5067.67 | 180 / 359 | 85% | 15.20 | 243 / 286 |
| adrenal gland | 53% | 1685.66 | 138 / 258 | 63% | 4.78 | 145 / 230 |
| ureter | 0% | 0 | 0 / 0 | 100% | 2.33 | 1 / 1 |
| muscle | 100% | 35899.93 | 800 / 803 | 0% | 0 | 0 / 0 |
| blood vessel | 99% | 19920.93 | 1326 / 1335 | 0% | 0 | 0 / 0 |
| ovary | 23% | 1310.14 | 41 / 180 | 76% | 5.05 | 328 / 430 |
| heart | 95% | 23162.16 | 820 / 861 | 0% | 0 | 0 / 0 |
| pancreas | 0% | 12.79 | 1 / 328 | 94% | 16.51 | 167 / 178 |
| thymus | 20% | 676.37 | 133 / 653 | 72% | 4.56 | 438 / 605 |
| kidney | 7% | 228.34 | 6 / 89 | 83% | 7.54 | 745 / 901 |
| tonsil | 0% | 0 | 0 / 0 | 80% | 8.01 | 36 / 45 |
| skin | 30% | 2194.34 | 550 / 1809 | 45% | 2.54 | 214 / 472 |
| adipose | 72% | 3210.41 | 864 / 1204 | 0% | 0 | 0 / 0 |
| brain | 0% | 2.58 | 2 / 2642 | 71% | 4.15 | 499 / 705 |
| lymph node | 0% | 0 | 0 / 0 | 48% | 1.75 | 14 / 29 |
| liver | 0% | 0 | 0 / 226 | 36% | 2.46 | 145 / 406 |
| spleen | 8% | 270.10 | 20 / 241 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 8% | 0.22 | 6 / 80 |
| peripheral blood | 1% | 19.20 | 6 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0007156 | Biological process | homophilic cell adhesion via plasma membrane adhesion molecules |
| GO_0030334 | Biological process | regulation of cell migration |
| GO_0007411 | Biological process | axon guidance |
| GO_0070593 | Biological process | dendrite self-avoidance |
| GO_0051493 | Biological process | regulation of cytoskeleton organization |
| GO_0015629 | Cellular component | actin cytoskeleton |
| GO_0030424 | Cellular component | axon |
| GO_0005912 | Cellular component | adherens junction |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0030018 | Cellular component | Z disc |
| GO_0005925 | Cellular component | focal adhesion |
| GO_0098632 | Molecular function | cell-cell adhesion mediator activity |
| GO_0051015 | Molecular function | actin filament binding |
| GO_0008307 | Molecular function | structural constituent of muscle |
| Gene name | NEXN |
| Protein name | Nexilin F-actin binding protein Nexilin (F-actin-binding protein) (Nelin) Nexilin f-actin binding protein |
| Synonyms | |
| Description | FUNCTION: Involved in regulating cell migration through association with the actin cytoskeleton. Has an essential role in the maintenance of Z line and sarcomere integrity. . |
| Accessions | Q0ZGT2 E7EUA0 ENST00000334785.12 [Q0ZGT2-1] A0A7R6RQ55 ENST00000401035.7 ENST00000330010.12 [Q0ZGT2-4] ENST00000342754.5 H7BXY5 A0A7R6M6R6 ENST00000440324.5 E7ETM8 |